Health Condition 1: D352- Benign neoplasm of pituitary gland
Conditions
Interventions
None listed
Sponsors
DR NITHISHA ROY
DR S MANIKANDAN
Eligibility
Inclusion criteria
Inclusion criteria: 1.Consenting adult patients undergoing endoscopic trans nasal trans-sphenoidal pituitary invasive adenomas and non- invasive pituitary adenomas at Sree Chitra Tirunal Institute for Medical Sciences and Technology. 2. Age 18-60 years 3.ASA (American Society of Anaesthesiologists) class 1 and 2 4.GCS 15/15 prior to the surgery
Exclusion criteria
Exclusion criteria: 1 .Patient refusal 2. Age less than 18 years and more than 60 years 3. Emergency surgery 4. Patients with previous history of stroke, transient ischemic attacks . 5. ASA class 3,4,5 patients 6.Patients with subarachnoid hemorrhage, vasospasm 7.Pregnant and lactating mothers 8.Transcranial surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To assess the utility of TCD in detecting vasospasm following endoscopic trans nasal surgeries for invasive pituitary adenoma & non-invasive pituitary adenoma. 2. To clinically correlate between the TCD flow velocities & neurological complications like altered mental status, motor deficits, seizures, diabetes insipidus, CT scan evidence of infarcts or SAH. 3 .To assess the risk factors for development of vasospam & neurological deficits in this subset of patients.Timepoint: TCD will be done before induction ,within 24hours of surgery,post operative day 3 & before discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidental findings are notified to surgeons & further management will be as per surgeons.Timepoint: During post operative days | — |
Countries
India
Contacts
Public ContactDR S MANIKANDAN
SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY
Outcome results
None listed